Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases ...

Newly-released figures show a staggering 110 out of 111 NHS trusts that have specialist ophthalmology units in the UK failed ...

Myopia is more than just a need for glasses If left untreated it can progress to high myopia and increase the risk of serious ...

European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...

Eye care should not begin only when vision becomes blurry. The eyes change through childhood, school years, adulthood, and older age, and each stage brings different risks. Children need healthy ...

Tavo Biotherapeutics Secures $17M to advance glaucoma and retinal disease therapies through clinical development and growth.

This spring, take Williamsburg up on everything it is offering — the trails, the rivers, the history, the fresh air. Just ...

Ophthalmologist and vitreoretinal specialist Dr. Bunyaporn (Mo) Chandra-Chamnong told members of the Pattaya City Expats Club ...

Sponsored by Eyedaptic and hosted by Jill Seawell, the new podcast explores the latest advancements transforming vision ...

Somewhere around 200 million people worldwide live with age-related macular degeneration, and for those with the dry form of ...

A decision on the resubmitted application is expected within 60 days of the FDA’s receipt of it, the company said.

New survey suggests far too many people dismiss potentially serious vision changes as part of ageing or eye strain.